BiotechTube
GreenLight Biosciences

GreenLight Biosciences

Medford, United States· Est.
greenlightbiosciences.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $299M

Overview

GreenLight Biosciences is a pioneer in applying RNA interference (RNAi) technology to agriculture, aiming to replace or augment chemical pesticides with highly specific, biodegradable RNA-based products. The company has achieved commercial validation with its first EPA-approved product, Calantha, for Colorado Potato Beetles, and has a robust pipeline targeting major pests and diseases. Its core differentiator is a scalable, cost-effective manufacturing platform designed to overcome the historical cost barriers to widespread agricultural RNA use. GreenLight positions itself at the intersection of agricultural productivity, environmental sustainability, and resistance management.

Agriculture

Technology Platform

Proprietary, scalable manufacturing platform for cost-effective production of double-stranded RNA (dsRNA) using a cell-free, enzymatic bioprocessing system.

Funding History

5
Total raised:$299M
PIPE$105M
Series D$122M
Series C$50M
Series B$17M

Opportunities

The global push to replace harmful chemical pesticides and combat pest resistance creates a massive market for effective, sustainable alternatives.
GreenLight's RNA platform can rapidly design solutions for a wide range of pests and diseases, enabling a broad pipeline.
Growing regulatory and consumer pressure for environmentally friendly agriculture accelerates adoption timelines for novel biologicals.

Risk Factors

Regulatory approval for novel RNA-based pesticides is complex and uncertain across different global jurisdictions.
Achieving cost-effective manufacturing at the massive scale required for agriculture remains an unproven challenge commercially.
Farmer adoption may be slow if products are priced higher than conventional chemicals or if performance is inconsistent in the field.

Competitive Landscape

GreenLight competes with large agrochemical companies (e.g., Bayer, Syngenta, Corteva) developing their own biological and RNA-based pipelines, as well as with other biotech startups in the ag biologicals space. Competition is based on efficacy, cost, ease of use, and the breadth of the solution portfolio. GreenLight's claimed manufacturing advantage is a key differentiator if proven at full scale.

More companies in Synthetic Biology →More companies in United States →